• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Conceptus swaps out $50 million in senior notes | Funding Roundup

Conceptus swaps out $50 million in senior notes | Funding Roundup

January 3, 2012 By MassDevice staff

Conceptus Inc. logo

Conceptus (NSDQ:CPTS) swapped out $50 million worth of 2.25% senior notes due 2027 from a select group of holders, exchanging them for 5% notes due 2031, regulatory filings show.

The principal amount on the new notes was an even swap for the originals, which was determined in individual negotiations between Conceptus and the holders.

The subscription agreement follows the sudden swap of former CEO Mark Sieczkarek and promotion of Keith Grossman to president upon lowering of 2012 guidance for the Mountain View, Calif.-based contraceptive devices maker.

Early in December Conceptus also announced that it canceled its $50 million revolving credit line with Wells Fargo Bank citing uncertainty about being able to meet "certain financial covenants."

Later in the month the company revealed that it entered into an Indenture with Wells Fargo as a trustee in connection with the note exchange.

The new notes are convertible into cash, shares of common stock or a combination of the two, according to filings.

Funding

Here’s a roundup of other dealflow and investment news:

Clear Catheter Systems closes first round of funding with $4 million

Clear Catheter Systems Inc., developer of medical devices used in post-surgical recovery, closed its first institutional round of financing. The $4 million round was co-led by Aphelion Capital and California Technology Ventures.
Read more

Velomedix nears close of $10.7M round
Menlo Park, Calif.-based therapeutic hypothermia device maker Velomedix Inc. raised $9.3 million of a hoped-for $10.7 funding round.
Read more

Lucid closes $5.3 million funding round

Lucid Inc. (OTCBB: LCDCU) closed its public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock. Net proceeds were approximately $5.30 million, after deducting the underwriting discount and corporate finance fee, but before taking into account estimated offering expenses. Read more

iCad touts $15 million debt facility
iCad Inc. (NSDQ: ICAD), provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, entered into a 5 year, $15 million debt facility agreement with Deerfield Management Company LP. Read more

ProUroCare borrows $80,000
ProUroCare Medical Inc. borrowed $40,000 from each of Larry Musich and Alisa Piazza pursuant to promissory notes. The unsecured promissory notes bear interest at 10% per annum and mature on March 22, 2012. In addition, pursuant to the terms of the Piazza note, the company issued to the lender a five-year warrant to purchase 17,500 shares of the company’s common stock at $1.30 per share.
Read more

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Clearflow, Conceptus Inc., iCad Inc., Lucid Inc., ProUroCare Medical Inc., Velomedix Inc.

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy